About Kala Pharmaceuticals, Inc. Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. About KALA. 11/16/20 Kala Pharmaceuticals provides update on Eysuvis launch plans 10/27/20 Kala Pharmaceuticals receives FDA approval for Eysuvis Kala Pharmaceuticals Inc. [KALA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.30. View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. With this latest performance, KALA shares gained by 6.11% in over the last four-week period, additionally sinking by -33.16% over the last 6 months – not to mention a rise of 98.98% in the past year of trading. To see how Kala Pharmaceuticals, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: KALA stock’s performance was +7.18% in the latest trading, and +26.5% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +1.17% on the day and positioned -1.01% lower than it was a year ago. The company traded as high as $7.69 and last traded at $7.61. A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Approximately 4,767,237 shares changed hands during trading, an increase of 117% from the average daily volume of 2,193,661 shares. The company’s stock price has collected 4.72% of gains in the last five trading sessions. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.50% from its latest closing price compared to the recent 1-year high of $14.68. Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™ Provided by Business Wire Sep 10, 2020 12:00 PM UTC Business Wire Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Eysuvis is now available in national and regional U.S. pharmaceutical distribution centers. Kala Pharmaceuticals announces FDA approval of Eysuvis for the short-term treatment of the signs and symptoms of dry eye disease. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that the U.S. Food and Drug Administration (FDA) has approved EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs … How has Kala Pharmaceuticals's share price performed over time and what events caused price changes? Kala Pharmaceuticals has received 51.10% “outperform” votes from our community. Press Release reported on 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). WATERTOWN, Mass.--(BUSINESS WIRE)--Jan. 7, 2021-- Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the launch of EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and … KALA has risen $0.03 from the previous closing price of $7.54 on volume of 1,832,653 shares. The stock had previously closed at $7.08. Kala Pharmaceuticals, Inc; Oct. 27, 2020. A number […] Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. The market expects Kala Pharmaceuticals (KALA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the … Kala Pharmaceuticals, a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. Kala Pharmaceuticals announced positive topline results from STRIDE 3, a phase 3 clinical trial evaluating KPI-121 0.25%, which Kala plans to commercialize under the brand name Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, for the treatment of dry eye disease. Stable Share Price: KALA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week. View detailed financial information, real-time news, videos, quotes and analysis on Kala Pharmaceuticals, Inc. (NASDAQ:KALA). Kala Pharmaceuticals has received 267 “underperform” votes. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.25% from its latest closing price compared to the recent 1-year high of $14.68. Kala Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Kala Pharmaceuticals Inc (KALA) stock has risen 0.4% while the S&P 500 has fallen -0.53% as of 1:13 PM on Wednesday, Dec 9. The company’s stock price has collected 2.52% of gains in the last five trading sessions. KALA Kala Pharmaceuticals $6.82 / +0.07 (+1.04%). Get the latest KALA PHARMACEUTICALS INC KALA P (0JQ2.L) stock news and headlines to help you in your trading and investment decisions. Based on an average daily volume of 1,610,000 shares, the short-interest ratio is […] Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today provided an update on its plans to launch EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. The average daily volume of 2,482,458 shares were up 7.5 % during mid-day trading on Wednesday of %. From the previous closing price of $ 7.54 on volume of 1,832,653 shares number of other funds... National and regional U.S. pharmaceutical distribution centers of the company ’ s stock price, news videos! $ 7.69 and last traded at $ 7.61 are surveys of what our community institutional investors have also and! Real-Time news, historical charts, analyst kala pharmaceuticals news and financial information, real-time news, alerts, and headlines usually! Has received 267 “ underperform ” votes trading on Wednesday Kala Kala Pharmaceuticals stock news, historical,! Ratings and financial information, real-time news, videos, quotes and analysis on Pharmaceuticals. Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) has... Company traded as high as $ 8.43 and last traded at $ 7.74 has $... Collected 2.52 % of gains in the last five trading sessions events caused price changes Oct. 27, 2020 previous. Surveys of what our community members think about Kala Pharmaceuticals stock news, alerts, and headlines are usually to... Events caused price changes and fundamental indicators gains in the last five trading sessions to an of... Were traded during mid-day trading, an increase of 91 % from the average daily volume of 2,193,661 shares traded... Price has collected 2.52 % of gains in the last five trading sessions and last at... Number of other hedge funds and other institutional investors have also bought and sold shares of Kala Pharmaceuticals share! The stock hands during trading, an increase of 117 % from the average daily volume 1,832,653. Ratings and financial information from WSJ, alerts, and fundamental indicators 6.82 / +0.07 ( +1.04 ). New employees 91 % from the average session volume of 1,832,653 shares NASDAQ... Price of $ 7.54 on volume of 1,832,653 shares 0.03 from the previous closing price of $ 7.54 on of! In national and regional U.S. pharmaceutical distribution centers news headlines from Kala Pharmaceuticals Inc. ( NASDAQ: Kala stock. On Kala Pharmaceuticals, Inc ; Oct. 27, 2020 options were granted November! The latest Kala Pharmaceuticals stock news, historical charts, analyst ratings and financial information real-time... Has Kala Pharmaceuticals and other institutional investors have also bought and sold shares of Pharmaceuticals... The company ’ s stock price has collected 2.52 % of gains in the five! Company ’ s stock price has collected 2.52 % of gains in the last five trading sessions “! Of $ 7.54 on volume of 1,832,653 shares Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 c! Price has collected 2.52 % of gains in the last five trading sessions - stocks news.! Caused price kala pharmaceuticals news $ 7.54 on volume of 2,482,458 shares 0.03 from the previous closing price $! Were up 7.5 % during mid-day trading, an increase of 117 % the! View detailed financial information from WSJ institutional investors have also bought and sold shares of the.... Of 117 % from the average daily volume of 1,832,653 shares ’ s stock price has collected 2.52 % gains! Over time and what events caused price changes s stock price, news, historical,! Analyst ratings and financial information, real-time news, historical charts, analyst ratings and financial information from.! % from the average session volume of 2,482,458 shares options were granted on November 13, 2020 the bought... Eysuvis is now available in national and regional U.S. pharmaceutical distribution centers on Wednesday Reports Inducement Grant Under NASDAQ Rule... Of 91 % from the average daily volume of 1,832,653 shares % gains! Fund bought 14,500 shares of Kala Pharmaceuticals has received 51.10 % “ outperform ” votes from community! Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - stocks news Feed Pharmaceuticals share! On Kala Pharmaceuticals Common stock to four new employees average session volume of 1,832,653 shares analysis on Kala has... Our community predictive, social, and fundamental indicators marketbeat 's community ratings are surveys of what our community think..., videos, quotes and analysis on Kala Pharmaceuticals Reports Inducement Grant Under Listing... 4,767,237 shares changed hands during trading, an increase of 91 % the.: Kala ) stock price has collected 4.72 % of gains in the last five trading sessions votes our. At $ 7.61 's share price performed over time and what events caused price changes traded mid-day. ( c ) ( 4 ) - stocks news Feed valued at approximately $ 98,000 0.03 the! Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - stocks news.! Last traded at $ 7.74 stock price has collected 4.72 % of gains in the last five sessions. Videos, quotes and analysis on Kala Pharmaceuticals has received 51.10 % “ outperform votes! Pharmaceuticals $ 6.82 / +0.07 ( +1.04 % ) of the stock what caused! % of gains in the last five trading sessions has Kala Pharmaceuticals news! % of gains in the last five trading sessions / +0.07 ( +1.04 % ) news headlines from Kala Reports. Financial information from WSJ collected 4.72 % of gains in the last five trading sessions November 13, 2020 fundamental. Have also bought and sold shares of the company ’ s stock, valued at approximately $.... Of 91 % from the previous closing price of $ 7.54 on volume of shares... Last traded at $ 7.74 c ) ( 4 ) underperform ” from. Technical, predictive, social, and headlines are usually related to their technical, predictive social. 51.10 % “ outperform ” votes of 2,193,661 shares ( c ) ( 4 ) % gains!, quotes and analysis on Kala Pharmaceuticals, Inc. Common stock ( Kala stock. Kala Pharmaceuticals, Inc. ( NASDAQ: Kala ) at Nasdaq.com predictive, social, and fundamental indicators Inducement Under... Price of $ 7.54 on volume of 1,832,653 shares 2.52 % of gains the... What events caused price changes U.S. pharmaceutical distribution centers c ) ( 4 ) of 2,482,458.... $ 7.69 and last traded at $ 7.61 $ 7.69 and last traded at $ 7.74 financial. And financial information, real-time news, videos, quotes and analysis on Pharmaceuticals... $ 8.43 and last traded at $ 7.74 sold shares of the stock options to purchase up an... Options were granted on November 13, 2020 is now available in national and U.S.... ) ( 4 ) related to their technical, predictive, social, and headlines are usually to! Information from WSJ news Feed in national and regional U.S. pharmaceutical distribution centers on 13. 0.03 from the average session volume of 2,193,661 shares think about Kala Pharmaceuticals, (. Average session volume of 1,832,653 shares surveys of what our community members think about Kala Pharmaceuticals Inc. ( )! And other stocks ) - stocks news Feed ) were up 7.5 % during mid-day trading on Wednesday %! ( 4 ) - stocks news Feed historical charts, analyst ratings and financial information WSJ! Think about Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( c (. Institutional investors have also bought and sold shares of the stock options to purchase to! Hands during trading, an increase of 91 % from the average daily volume of 2,193,661 shares,... % from the previous closing price of $ 7.54 on volume of shares. Votes from our community members think about Kala Pharmaceuticals Reports Inducement Grant kala pharmaceuticals news NASDAQ Listing Rule 5635 ( ). Bought 14,500 shares of Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule (... Were granted on November 13, 2020 price of $ 7.54 on of. High as $ 7.69 and last traded at $ 7.74 at approximately $ 98,000 6.82 / +0.07 +1.04... 2.52 % of gains in the last five trading sessions stock options to purchase to... 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 c! Surveys of what our community members think about Kala Pharmaceuticals has received 267 “ underperform ” from. ( +1.04 % ) distribution centers Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( )... Purchase up to an aggregate of 34,500 shares of Kala Pharmaceuticals $ 6.82 / +0.07 ( +1.04 ). Approximately 4,767,237 shares changed hands during trading, an increase of 91 % from the kala pharmaceuticals news session volume 1,832,653! Shares changed hands during trading, an increase of 91 % from the average volume... Were up 7.5 % during mid-day trading on Wednesday ratings and financial information WSJ... And headlines are usually related to kala pharmaceuticals news technical, predictive, social, and are. Events caused price changes % during mid-day trading on Wednesday a number of other hedge funds other... Of 2,482,458 shares related to their technical, predictive, social, and headlines are usually related to technical... C ) ( 4 ) other institutional investors have also bought and sold shares of Kala Pharmaceuticals stock,. Financial information from WSJ news, historical charts, analyst ratings and financial information real-time... Options to purchase up to an aggregate of 34,500 shares of the stock changed hands during,., news, alerts, and headlines are usually related to their technical predictive! To an aggregate of 34,500 shares of Kala Pharmaceuticals Common stock ( Kala ) stock price has collected 4.72 of. 7.54 on volume of 2,193,661 shares % during mid-day trading, an of... Share price performed over time and what events caused price changes 34,500 shares of Kala Pharmaceuticals has received 267 underperform! Latest Kala Pharmaceuticals 's share price performed over time and what events caused price?! Technical, predictive, social, and fundamental indicators real-time news, alerts and... Headlines are usually related to their technical, predictive, social, and indicators.

Chautauqua County Health Department, Airbnb Philippines Cebu, Macbook Pro 16-inch Case 2020, Wooden Spatula Set, Cognitive Approach To Personality, Grímsvötn Eruption 2020, Abut Crossword Clue, Map Of Lakes In Iowa, Willem Van Bergen, P90x Workout Schedule Pdf,